Literature DB >> 2787829

Chronic obstructive lung disease in Copenhagen: cross-sectional epidemiological aspects.

P Lange1, S Groth, J Nyboe, M Appleyard, J Mortensen, G Jensen, P Schnohr.   

Abstract

We analysed data from the Copenhagen City Heart Study to study the prevalence, possible risk factors for, and inter-relations between bronchial hypersecretion (BH) and chronic airflow limitation. The study sample consisted of 12,698 subjects between 20 years and 90 years of age, randomly selected from the population of the city of Copenhagen. The age-adjusted overall prevalence of BH in the population of Copenhagen was estimated to be 10.1%; 12.5% in men and 8.2% in women. The overall prevalence of clinically relevant chronic airflow limitation (forced expiratory volume in 1 s less than 60% of that predicted) was 3.7% and not significantly different between sexes. Both airflow limitation and BH increased with age, smoking, alcohol consumption, short education, and low income. However, the association of airflow limitation with alcohol consumption, education and income was much weaker than the association with smoking. Regardless of smoking habits, the majority of subjects with airflow limitation did not report symptoms of bronchial hypersecretion.

Entities:  

Mesh:

Year:  1989        PMID: 2787829     DOI: 10.1111/j.1365-2796.1989.tb01349.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  13 in total

1.  Chronic Bronchitis: Where Are We Now?

Authors:  Yaniv Dotan; Jennifer Y So; Victor Kim
Journal:  Chronic Obstr Pulm Dis       Date:  2019-04-09

2.  Sex Differences in Trajectories of Risk After Rehospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia.

Authors:  Rachel P Dreyer; Kumar Dharmarajan; Angela F Hsieh; John Welsh; Li Qin; Harlan M Krumholz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-05

3.  Changes in prevalence of chronic obstructive pulmonary disease and asthma in the US population and associated risk factors.

Authors:  Cara N Halldin; Brent C Doney; Eva Hnizdo
Journal:  Chron Respir Dis       Date:  2014-12-24       Impact factor: 2.444

Review 4.  The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications.

Authors:  Victor Kim; Gerard J Criner
Journal:  Curr Opin Pulm Med       Date:  2015-03       Impact factor: 3.155

5.  Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents.

Authors:  P S Bakke; V Baste; R Hanoa; A Gulsvik
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

Review 6.  Chronic bronchitis and chronic obstructive pulmonary disease.

Authors:  Victor Kim; Gerard J Criner
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

7.  Arterial oxygen saturation, COPD, and cerebral small vessel disease.

Authors:  E J van Dijk; S E Vermeer; J C de Groot; J van de Minkelis; N D Prins; M Oudkerk; A Hofman; P J Koudstaal; M M B Breteler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

8.  Decline of the lung function related to the type of tobacco smoked and inhalation.

Authors:  P Lange; S Groth; J Nyboe; J Mortensen; M Appleyard; G Jensen; P Schnohr
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

9.  Spirometric testing on World COPD Day.

Authors:  Tanja Grzetic-Romcevic; Boris Devcic; Silvana Sonc
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-02-10

10.  Prevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi Arabia.

Authors:  Mohammed Al Ghobain; Mohamed S Al-Hajjaj; Siraj Omar Wali
Journal:  Ann Saudi Med       Date:  2011 Mar-Apr       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.